Top compounds associated with response to RABL6


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.05 0.1
mRNA bid1870 gCSI pan-cancer AAC -0.089 0.1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.1
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.053 0.1
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.057 0.1
mRNA tivantinib CTRPv2 pan-cancer AAC 0.068 0.1
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA Imatinib FIMM pan-cancer AAC -0.27 0.1
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.051 0.1
Download CSV